Cyclophosphamide

Breastfeeding
  • TRADE NAMES: Cycloblastin; Cyclostin; Cytoxan (Mead Johnson); Endoxan; Endoxana; Genoxal; Ledoxina; Neosar (Gensia); Procytox; Sendoxan
  • INDICATIONS: Lymphomas; minimal change nephrotic syndrome in pediatric patients
  • SYNONYM: CPM; CTX; CYT
  • CLASS: Alkylating agent
  • HALF-LIFE: 3–12 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Aldesleukin, Azathioprine, Belimumab, Clozapine, Cyclopenthiazide, Cyclosporine, Dexamethasone, Etanercept, Itraconazole, Mycophenolate, Pentostatin, Prednisone, Vaccines

PREGNANCY CATEGORY: D

Contra-indicated in patients with urinary outflow obstruction.

Our database has 159 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 01/31/2024

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top